Ex-Naval Medical Officer & Merck Veteran Vlad Hogenhuis Describes Life In Leadership At GSK
Executive Summary
Dr Vlad Hogenhuis, a Merck & Co. Inc. veteran who joined GlaxoSmithKline PLC in 2012, is currently responsible for the UK company's vast speciality franchise – formulating a global strategy for novel drug development and product launches in the areas of cardiovascular, neuroscience, immunology, oncology, infectious disease, dermatology and a small group of additional diseases. These are markets of significant potential and unmet need for patients, comprising over £280bn in total sales for 2015.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.